Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products
- 15 May 1988
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 252 (1) , 47-54
- https://doi.org/10.1042/bj2520047
Abstract
The interactions of properdin with both surface-bound and fluid-phase C3 (the third component of complement) and its activation products have been investigated by using a purified preparation of the ''native'' form. At physiological ionic strength, a weak interaction with cell-bound C3b (the larger activation fragment of C3) could be demonstrated. In the presence of Factor B this interaction was enhanced, and further enhancement was seen when C3bBb sites were formed on the erythrocytes. The avidities of properdin for cell-bound iC3b (the initial product of Factors I and H action on C3b) and C3b were compared at low ionic strength, with that measured for iC3b being less than that for C3b. In contrast, the affinities of properdin for fluid-phase C3b, iC3b and C3c (the larger product of Factors I and H or CR1 (the C3b receptor) action on iC3b) were all very similar, and apparently much weaker than that for cell-bound C3b. No interaction with either native C3 or, more surprisingly, C3i (haemolytically inactive C3) could be detected. Properdin also inhibited Factor I binding to, and action upon, cell-bound C3b, but did not inhibit Factor I action on fluid-phase C3b. These data permit a more detailed description of the roles of properdin in the alternative pathway of complement activation, emphasizing its importance in concentrating activation at the activating surface.This publication has 40 references indexed in Scilit:
- The alternative pathway of complementSpringer Seminars in Immunopathology, 1984
- Monoclonal antibodies against the complement control protein Factor H (β1 H)Bioscience Reports, 1983
- Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.The Journal of Experimental Medicine, 1982
- Amino acid sequence studies of human properdin—N-terminal sequence analysis and alignment of the fragments produced by limited proteolysis with trypsin and the peptides produced by cyanogen bromide treatmentMolecular Immunology, 1981
- Pattern of degradation of human complement fragment, C3bFEBS Letters, 1981
- Treatment of Human Complement Components C4 and C3 with Amines or Chaotropic IonsScandinavian Journal of Immunology, 1981
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.The Journal of Experimental Medicine, 1976
- Studies on the sub-unit structure of human properdinImmunochemistry, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970